Truist Financial Corporation, a financial services company, provides banking and trust services in the Southeastern and Mid-Atlantic United States. The company operates through two segments, Consumer and Small Business B…
Industry Peers
Banks - Regional| Headline | Source | Time |
|---|---|---|
Yesterday | ||
CFG Q2 Earnings Top on NII & Fee Income, Raised NIM View Lifts Stock Citizens Financial's shares rise 3.9% in early trading after Q2'26 results benefit from higher NII and fee income growth, while a raised NIM outlook boosts sentiment. | ||
FHN Shares Fall Despite Q2 Earnings Beat on Higher NII & Fee Income First Horizon's Q2'26 results gain from higher NII, fee income and balance growth. Yet, shares fall nearly 3% as expenses rise and capital ratios weaken. | ||
U.S. Bancorp Q2 Earnings Beat Estimates on NII & Fee Revenue Growth USB tops Q2 earnings estimates as higher net interest income, fee revenue growth and loan expansion offset higher credit provisions. | ||
Will Loan Growth, Fee Income Strength Drive KeyCorp's Q2 Earnings? KEY's Q2 earnings are likely to have gained from C&I loan demand, higher NII and stronger fee income despite pressure in mortgage banking and higher expenses. | ||
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, BlackRock, Etsy, Flex, Lululemon Athletica, Meta Platforms, Okta, Palo Alto Networks, and More Wall Street analysts are reshuffling their bets on Thursday, sending some of the market's biggest names in opposite directions as geopolitical tensions and inflation crosscurrents cloud the outlook. Find out which stocks got upgraded, downgraded, or newly covered today. | ||
UnitedHealth Group (UNH) Stock Sees Modest Fair Value Lift As Analysts Raise Targets UnitedHealth Group is back in focus as analysts adjust their price targets, with updated fair value estimates now set at US$424.23 compared with the prior US$411.31. Behind these tweaks, recent research has weighed steadier views on Medicare Advantage, Medicaid and ACA exchanges against mixed opinions on medical cost pressures and the durability of current trends. As you read on, you will see how these shifting signals feed into the evolving analyst narrative and what to watch next in... | ||
Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the Week Today Earnings (a.m): UnitedHealth, GE Aerospace, U.S. Bancorp, Citizens Financial, Abbott Laboratories, State Street, Taiwan Semiconductor Manufacturing Earnings (p.m.): Netflix, Intuitive Surgical Economic data: Weekly jobless claims, Philadelphia Fed business-outlook survey, retail sales, pending home sales index, business inventories Fed speakers: Fed Vice Chair Philip Jefferson is expected to speak, as is Dallas Fed President Lorie Logan. | ||
Truist Financial (TFC) Reports Earnings Tomorrow: What To Expect Financial services company Truist Financial (NYSE:TFC) will be announcing earnings results this Friday morning. Here’s what you need to know. | ||
Truist (TFC) Stock Stays Reasonable On Its 73% Three Year Run After a strong three year return of 73.1%, Truist Financial’s share price now sits against a valuation set up where both the Excess Returns intrinsic value estimate and the earnings based multiples still point to the stock trading below their implied levels, while the broader checks look more balanced. Truist Financial has returned 73.1% over three years, which puts extra weight on whether that gain is fully backed by fundamentals or leaves more room relative to intrinsic value... | ||
This week | ||
Truist Upgrades Global-E Online (GLBE) to Buy Global-E Online Ltd. (NASDAQ:GLBE) is one of the 10 Fastest Growing Consumer Stocks to Buy Now. On June 10, 2026, Truist analyst Matthew Coad upgraded Global-E Online Ltd. (NASDAQ:GLBE) to Buy from Hold with a price target of $39, up from $34. Matthew Coad said Truist is “more optimistic” on Global-E’s volume growth, citing “strong” […] | ||
Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN) Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the 10 affordable biotech stocks to buy right now. On June 30, Goldman Sachs increased its target price for Viridian Therapeutics Inc. (NASDAQ:VRDN) from $35 to $39, implying an adjusted upside potential in excess of 105% at the prevailing level. The firm maintained its Buy rating on the […] | ||
APA (APA) Stock Gets Fair Value Trim As Analysts Weigh Oil Upside And Risks APA's fair value price target has been updated to US$42.13 from US$43.24, reflecting a small reset in the modeled intrinsic value of the stock. This shift comes as analysts weigh upside linked to APA's oil exposure and exploration projects against commodity sensitivity and execution risks, which is showing up in a wide spread of ratings and targets. Read on to see how these moving pieces fit together and how you can track the evolving analyst narrative around APA. Analyst Price Targets don't... | ||
Truist Says Devon Energy’s (DVN) Next Earnings Report Could Be a Turning Point With an upside potential of 40.92%, Devon Energy Corporation (NYSE:DVN) is among the 12 Strong Buy Stocks with High Upside According to Analysts. On July 9, Truist lowered its price target on Devon Energy Corporation (NYSE:DVN) to $61 from $66 while maintaining a Buy rating ahead of the company’s second-quarter results. The firm expects the upcoming quarter […] | ||
Truist Cuts PT on ConocoPhillips (COP) Following Q2 ConocoPhillips (NYSE:COP) is one of the top cheap blue chip stocks to buy according to Wall Street analysts. Truist cut the price target on ConocoPhillips (NYSE:COP) to $115 from $128 on July 8 and maintained a Hold rating on the shares. The rating update came as part of a preview of its fiscal Q2 results, […] | ||
Truist Remains Bullish on Zymeworks (ZYME) – Here’s Why Zymeworks Inc. (NASDAQ:ZYME) is one of the best small cap stocks to buy with the highest upside potential. Truist lifted the price target on Zymeworks Inc. (NASDAQ:ZYME) to $31 from $28 on July 7 and maintained a Buy rating on the shares. The rating update came as part of a broader research note, with the firm […] | ||
Brown & Brown Faces Tough Property Quarter With Relief Expected in Q3, Truist Says Brown & Brown's (BRO) Q2 could be pressured by escalating declines in coastal property and a higher | ||
KeyCorp (KEY) Reports Next Week: Wall Street Expects Earnings Growth KeyCorp (KEY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | ||
Loan Growth, Fee Income Strength to Support Truist's Q2 Earnings TFC's Q2 earnings are likely to have benefited from loan growth and stronger fee income, even as expenses and non-performing assets weigh on performance. | ||
Why Did SMR, RR, FAC Stocks Plummet To 52-Week Lows? NuScale Power, Richtech Robotics, and Factorial Energy fell to 52-week lows on Monday amid a slew of company-related updates that weighed on their stocks. | ||
Older | ||